7 Best Stocks for the Next 30 Days

Get them in a free Special Report, and get more Zacks Insights in our free e-newsletter, Profit from the Pros. Every issue includes a fresh Zacks #1 Bull Stock of the Day.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/21/2013

Company Name Symbol %Change
SCIENTIFIC L SCIL
8.00%
NATUS MEDICA BABY
6.11%
SUMMER INFAN SUMR
6.02%
RADIANT LOGI RLGT
5.32%
NEW ORIENTAL EDU
4.51%

Sysco Surpasses Estimates

by Zacks Equity Research

February 06, 2012 | Comments : 0 Recommended this article: (0)
SYY

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

Sysco Corp. ( SYY - Snapshot Report ) delivered second-quarter 2012 earnings (excluding one-time items) of 46 cents per share, which exceeded the Zacks Consensus Estimate of 44 cents. It also exceeded the prior-year earnings of 45 cents per share.

The second-quarter 2012 results exclude the negative impact from gross business transformation expenses of 3 cents, while the second-quarter 2011 earnings exclude 3 cents of negative impact from gross business transformation expenses, partially offset by a 2 cents gain from corporate-owned life insurance (COLI).

Revenue and Operating Income

Sysco's sales advanced 9.2% on a year-over-year basis, to $10.2 billion in the second-quarter of 2012. Acquisition contributed to the sales by 0.7%, while unfavorable currency translation decreased sales by 0.1%. However, food cost inflation increased to 6.3% in the quarter versus 4.5% in the prior-year quarter, which negatively impacted the quarterly sales.

Sales exceeded the Zacks Consensus Estimate of $10.04 billion.

Operating income increased 2.5% in the quarter, excluding gross business transformation expenses and the impact of COLI. However, Sysco's operating income lowered 2.3% in the quarter to $427 million on a reported basis.

Other Financial Updates

Sysco generated $539 million of cash from operations in the first half of 2012, as compared to the $283 million in the prior-year. The company also spent $434 million as capital expenditure in the first half of 2012 related to facility replacements and expansions, replacements to Sysco's fleet, and technology. The company’s capital expenditure included $79 million related to the company's business transformation project.

Cash and cash equivalents were $336.5 million at the end of December 31, 2011, while long-term debt was $2.65 billion.

Headquartered in Houston, Texas, Sysco's multi-year business transformation project is on track, employing 300 full-timers. The company is through with the design and technology development work. Presently, it is testing systems and processes.

We currently have a Zacks #4 Rank on Sysco shares, which translates into a short-term Sell rating. Sysco is the global leader in selling, marketing and distributing food products, and operates 177 distribution facilities serving approximately 400,000 customers. For fiscal year 2011 that ended July 2, 2011 the company generated record sales of more than $39 billion.

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.